Skip to main content
SpringerLink
Log in

Signal transduction

Barriers come down

  • News & Views
  • Published:

From Nature

View current issue Submit your manuscript

A protein known as erythropoietin might be useful in preventing the death of nerve cells in acute brain injury. But how does it work? Crosstalk between two signalling pathways could be the answer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Crosstalk between two seemingly disparate signalling pathways.

References

  1. Digicaylioglu, M. & Lipton, S. A. Nature 412, 641–647 (2001).

    Article  CAS  Google Scholar 

  2. Sirén, A. L. et al. Proc. Natl Acad. Sci. USA 98, 4044–4049 (2001).

    Article  Google Scholar 

  3. Livolsi, A. et al. Eur. J. Biochem. 268, 1508–1515 (2001).

    Article  CAS  Google Scholar 

  4. Lezoualc'h, F. et al. J. Neurosci. 18, 3224–3232 (1998).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, 20892-1876, Maryland, USA

    Ulrich Siebenlist

Authors
  1. Ulrich Siebenlist
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich Siebenlist.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Siebenlist, U. Barriers come down. Nature 412, 601–602 (2001). https://doi.org/10.1038/35088174

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/35088174

  • Springer Nature Limited

This article is cited by

Search

Navigation